82 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
for the interest for the nine-month period ended December 31, 2023.
Investigation of Patient Assistance Programs
In June 2019, the DOJ (through the U.S … was cooperating with the investigation and in December 2023, Takeda reached a settlement for an amount that is immaterial. The settlement had no material impact
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
Cancer Center and an expert in the management of TTP 1 TAK-755 has not been approved for the use or indications under investigation in clinical trials
S-8
EX-5.1
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
not made any independent investigation in respect of the matters which are the subject of such assumption or qualification.
Furthermore, our opinion stated
6-K
EX-99.1
vv2jzxmx5tzdoci4dya
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
o11wre7kc5u6kt9
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
vcltrj 9exzx6fbp
30 May 23
Current report (foreign)
6:11am
6-K
o7mlfuhr2iocr
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
um1jz9eu ho
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
kgy8 k6w0evw
31 May 22
Current report (foreign)
12:00am
6-K
av4rkqtwspay gll
11 May 22
Current report (foreign)
6:06am
6-K
evecv8b7gx 0te
10 Feb 22
Current report (foreign)
6:03am
6-K
doefz n6n6
3 Feb 22
Current report (foreign)
6:09am
6-K
vncqnr
5 Nov 21
Current report (foreign)
6:02am
6-K
asgaq8vi
1 Nov 21
Current report (foreign)
6:04am
S-8
EX-5.1
x4lcb
28 Oct 21
Registration of securities for employees
6:33am
6-K
hy9mjfd5f2vtbky8uc
28 Oct 21
Current report (foreign)
6:12am
6-K
c3xzfa43atrp5c4cax
1 Oct 21
Current report (foreign)
6:03am